<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92321">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01786954</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00036498</org_study_id>
    <nct_id>NCT01786954</nct_id>
  </id_info>
  <brief_title>iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery</brief_title>
  <official_title>A Comparative Study of Icare Rebound Tonometry With Other Tonometry Modalities in Patients Following Vitreoretinal Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the measurement of pressure inside the eye using
      three different FDA-approved devices (Icare, Tonopen, and Goldmann applanation).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The three above devices will be used to measure intraocular pressure in patients one day
      following vitreoretinal surgery. The underlying reason for surgery is not being considered
      in this study. The measured pressures will be compared across devices in eyes filled with
      fluid, gas, and silicone oil.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>measurement of intraocular pressure</measure>
    <time_frame>postoperative day #1</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome is the measurement of intraocular pressure on postoperative day #1 following vitreoretinal surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>postoperative day #1</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The secondary outcome is the onset of any adverse events related to measurement of intraocular pressure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Intraocular Pressure</condition>
  <arm_group>
    <arm_group_label>Icare, Goldmann, Tonopen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enrolled patients will be subjected to intraocular pressure measurement using Icare rebound tonometry, Tonopen applanation, and Goldmann applanation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Icare rebound tonometry</intervention_name>
    <arm_group_label>Icare, Goldmann, Tonopen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tonopen applanation</intervention_name>
    <arm_group_label>Icare, Goldmann, Tonopen</arm_group_label>
    <other_name>Tonopen Avia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Goldmann applanation</intervention_name>
    <arm_group_label>Icare, Goldmann, Tonopen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Duke Eye Center patients 18 years or older

          -  capacity to give legally effective consent

          -  scheduled to undergo vitreoretinal surgery

        Exclusion Criteria:

          -  individuals unable to give consent

          -  minors
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Hahn, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Hahn, MD, PhD</last_name>
    <phone>919-684-5631</phone>
    <email>paul.s.hahn@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Eye Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Hahn, MD, PhD</last_name>
      <phone>919-684-5631</phone>
      <email>paul.s.hahn@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Hahn, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 3, 2014</lastchanged_date>
  <firstreceived_date>February 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitreoretinal surgery</keyword>
  <keyword>intraocular pressure</keyword>
  <keyword>applanation</keyword>
  <keyword>rebound</keyword>
  <keyword>tonometry</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
